CIK 0000727510 · Non-accelerated filer<br>Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222372868
- Phone
- (630) 874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-09-22 | del Campo Ralph COO and Principal Exec Officer | Grant or award | +15,000 | 177,633.14 | ||
| 2010-09-22 | HORAK IVAN D EVP, President of R&D and CSO | Grant or award | +15,000 | 135,188 | ||
| 2010-09-22 | Davit Paul Stephen Exec. Vice Pres. HR | Grant or award | +8,000 | 102,737.17 | ||
| 2010-09-17 | HORAK IVAN D EVP, R&D, CSO | Option exercise | +162,800 | $7.14 | $1.2M | 240,988 |
| 2010-09-17 | HORAK IVAN D EVP, R&D, CSO | Option exercise | +79,200 | $7.40 | $586K | 320,188 |
| 2010-09-17 | HORAK IVAN D EVP, R&D, CSO | Sale | −200,000 | $10.63 | $2.1M | 120,188 |
| 2010-09-17 | HORAK IVAN D EVP, R&D, CSO | Option exercise · Employee Stock Option (Right to Buy) | −162,800 | 0 | ||
| 2010-09-17 | HORAK IVAN D EVP, R&D, CSO | Option exercise · Employee Stock Option (Right to Buy) | −79,200 | 66,500 | ||
| 2010-09-16 | HORAK IVAN D EVP, R&D, CSO | Option exercise | +2,000 | $7.14 | $14K | 79,888 |
| 2010-09-16 | HORAK IVAN D EVP, R&D, CSO | Sale | −1,700 | $10.67 | $18K | 78,188 |
| 2010-09-16 | HORAK IVAN D EVP, R&D, CSO | Option exercise · Employee Stock Option (Right to Buy) | −2,000 | 162,800 | ||
| 2010-09-15 | HORAK IVAN D EVP, R&D, CSO | Option exercise | +35,000 | $6.97 | $244K | 99,888 |
| 2010-09-15 | HORAK IVAN D EVP, R&D, CSO | Option exercise | +35,200 | $7.14 | $251K | 135,088 |
| 2010-09-15 | HORAK IVAN D EVP, R&D, CSO | Sale | −57,200 | $10.81 | $618K | 77,888 |
| 2010-09-15 | HORAK IVAN D EVP, R&D, CSO | Option exercise · Employee Stock Option (Right to Buy) | −35,000 | 0 | ||
| 2010-09-15 | HORAK IVAN D EVP, R&D, CSO | Option exercise · Employee Stock Option (Right to Buy) | −35,200 | 164,800 | ||
| 2010-09-02 | HORAK IVAN D EVP, R&D, CSO | Option exercise | +20,000 | 71,972 | ||
| 2010-09-02 | HORAK IVAN D EVP, R&D, CSO | Shares withheld for taxes | −7,084 | $10.58 | $75K | 64,888 |
| 2010-09-02 | HORAK IVAN D EVP, R&D, CSO | Option exercise · Restricted Stock Units | −20,000 | 0 | ||
| 2010-08-26 | LEBUHN ROBERT Director | Sale | −4,600 | $10.50 | $48K | 111,919 |
Page 11 of 12 · 223 trades